Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy
- 31 January 2005
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 61 (1), 32-43
- https://doi.org/10.1016/j.ijrobp.2004.05.003
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experienceInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Minimizing prostate brachytherapy-related morbidityUrology, 2003
- Extracapsular Radiation Dose Distribution After Permanent Prostate BrachytherapyAmerican Journal of Clinical Oncology, 2003
- Permanent Interstitial Brachytherapy for the Management of Carcinoma of the Prostate GlandJournal of Urology, 2003
- Long‐term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinomaCancer, 2003
- A STANDARD DEFINITION OF DISEASE FREEDOM IS NEEDED FOR PROSTATE CANCER: UNDETECTABLE PROSTATE SPECIFIC ANTIGEN COMPARED WITH THE AMERICAN SOCIETY OF THERAPEUTIC RADIOLOGY AND ONCOLOGY CONSENSUS DEFINITIONJournal of Urology, 2002
- 10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Palladium-103 brachytherapy for prostate carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Potential role of various dosimetric quality indicators in prostate brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 1999